Authors: Cheng, LY Rivero, ME Garcia, CR McDermott, CD Keefe, KS Wiley, CA Soules, KA Bergeron-Lynn, G Vekich, S Zhang, KY Appelt, K Freeman, WR

Citation: Ly. Cheng et al., Evaluation of intraocular pharmacokinetics and toxicity of prinomastat (AG3340) in the rabbit, J OCUL PH T, 17(3), 2001, pp. 295-304

Authors: Ozerdem, U Mach-Hofacre, B Cheng, LY Chaidhawangul, S Keefe, K McDermott, CD Bergeron-Lynn, G Appelt, K Freeman, WR

Citation: U. Ozerdem et al., The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathy, CURR EYE R, 20(6), 2000, pp. 447-453

Authors: Shalinsky, DR Brekken, J Zou, H Bloom, LA McDermott, CD Zook, S Varki, NM Appelt, K

Citation: Dr. Shalinsky et al., Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: Single agent and combination chemotherapy studies, CLIN CANC R, 5(7), 1999, pp. 1905-1917